Web1 ott 2016 · A Phase II Study of Endoscopic Resection and Chemoradiation Therapy for Clinical Stage I Esophageal Carcinoma (JCOG 0508): A Report of Radiation Therapy Quality Assurance Program International Journal of Radiation Oncology Biology Physics - Netherlands doi 10.1016/j.ijrobp.2016.06.943. Full Text Web1 feb 2024 · Recently, a phase II trial of combined treatment of ER and CCRT for stage I ESCC [Japan Clinical Oncology Group (JCOG) trial 0508] has been completed [33].

総括報告書 - JCOG

Webcordance with the regimen in the JCOG 0508 study [27]. The che-motherapy regimen comprised continuous 5-fluorouracil (700 mg/m2/day, days 1–4 and 29–32) and cisplatin (70 mg/m2/day, days 1 and 29). The radiotherapy dose was 41.4 Gy/23 Fr/5 weeks (5 days/week) for cases with a negative resection margin and 50.4 WebJCOG）」班 JCOG0508 粘膜下層浸潤臨床病期 I 期 (T1N0M0)食道癌に対する 内視鏡的粘膜切除術（ EMR）と化学放射線併用治療の有効性 に関する非ランダム化検証的試験 … switch in twig

Efficacy of combined endoscopic resection and ... - ResearchGate

WebStandard treatment for clinical stage I esophageal cancer with submucosal invasion (T1b) has been surgical resection. We conducted a Phase II trial to evaluate the efficacy and … Web23 lug 2024 · Surgery is so far the most effective treatment for early-stage non-small cell lung cancer (NSCLC). Since the 1990s, the pathology spectrum of early-stage lung cancer has gradually changed because of the increased detection of ground-glass opacity (GGO). The findings from preoperative thin-section co … Web11 nov 2011 · The JCOG 9114 trial (Tables 2 and 3) was initiated on the basis of the results from JCOG 8808. When JCOG 9114 commenced in 1992, standard first-line therapy in patients with MBC was still ACT; however, the optimal use of MPA was unclear in this setting. The JCOG 9114 trial was thus conducted to determine the optimal use of MPA in … switch in touch football